,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,248,1,1,,552473,64957,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,328,1,1,,552473,64957,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
2,317434,6,2,,103575473,64957,Unspecified,,,81.0,IC50,Antimalarial activity against Plasmodium falciparum in LDH reporter assay,Confirmatory,18078758.0,
3,317435,6,2,,103575473,64957,Active,,,49.0,IC50,Toxicity in CHO cells,Confirmatory,18078758.0,
4,317436,4,4,,103575473,64957,Unspecified,,,,,Ratio of IC50 for CHO cells to IC50 for Plasmodium falciparum,Other,18078758.0,
5,735073,1,2,,103575473,64957,Unspecified,,,2500.0,IC50,Displacement of SYBR green I from salmon testes DNA assessed as compound treated with DNA followed by SYBR green I added relative to control,Confirmatory,23375791.0,
6,1259407,1,1,,363902178,64957,Inactive,,,,,CCRIS mutagenicity studies,Other,,
